Souhaitez-vous accéder aux communiqués récents ?

Myriad will share new data at the Society of Gynecologic Oncology (SGO) Annual Meeting April 10-13, including two oral presentations and two posters.

WASHINGTON, April 09, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Siemens Healthineers, a leading global medical technology provider pioneering...

MMI (Medical Microinstruments, Inc.) today announced the commercial launch in the U.S. of its Robotic Suture.

Knoxville, TN, April 09, 2026 (GLOBE NEWSWIRE) -- LivTech, a leading provider of comprehensive healthcare tech solutions specifically designed for long-term post-acute care, today announced the...

Bethesda, MD, April 09, 2026 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) today announced that Ferring Pharmaceuticals and the Astellas/Pfizer Alliance will serve as National...

Planned interim analysis from DENALI Part 2a showed a clearly differentiated response rate at 400mg QD 5:2 over 300mg QD 5:2 and comparable safety profiles between the two dose groupsAzenosertib...

Fort Lauderdale, FL, April 09, 2026 (GLOBE NEWSWIRE) -- The presence of microplastics and nanoplastics (MNPs) in the human heart has been gaining attention in recent years. A study back in 2024...

BRIDGEWATER, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the launch of bimatoprost ophthalmic solution 0.01% (2.5 mL, 5 mL and...

Solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor, demonstrated meaningful reductions in daily OFF time and improvements in sleep-related symptoms across two Phase 2 trialsMeeting...

JENA, Germany, April 09, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...